These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: The involvement of the catecholaminergic system in physostigmine-induced hyperactivity in rats.
    Author: Egbe PC.
    Journal: Arzneimittelforschung; 1982; 32(1):27-9. PubMed ID: 6460507.
    Abstract:
    Physostigmine-induced hyperactivity in rats was attenuated by reserpine 5 mg/kg) and haloperidol (0.025 mg/kg). Pretreatment with (bis-4-methyl-1-homopiperizinyl-his-carbonyl) disulphide (FLA-63) (2.5 mg/kg) resulted in physostigmine producing a biphasic effect on rats' locomotion while pretreatment with p-chloro-phenylalanine (pCPA) (300 mg/kg) did not significantly affect physostigmine-induced hyperactivity. The relevance of the catecholaminergic system in mediating physostigmine-induced hyperactivity is discussed.
    [Abstract] [Full Text] [Related] [New Search]